Water → 3-bromo-N-(5-cyanopyridin-2-yl)-N-methyl-6,7-dihydropyrazolo-[1,5-a]pyrazine-5(4H)-carboxamide
반응식
[C:1]([C:3]1[CH:4]=[CH:5][C:6]([N:9]([CH3:13])[C:10](Cl)=[O:11])=[N:7][CH:8]=1)#[N:2].[Br:14][C:15]1[CH:16]=[N:17][N:18]2[CH2:23][CH2:22][NH:21][CH2:20][C:19]=12.C(N(CC)CC)C.O>C1COCC1.CN(C)C1C=CN=CC=1>[Br:14][C:15]1[CH:16]=[N:17][N:18]2[CH2:23][CH2:22][N:21]([C:10]([N:9]([C:6]3[CH:5]=[CH:4][C:3]([C:1]#[N:2])=[CH:8][N:7]=3)[CH3:13])=[O:11])[CH2:20][C:19]=12참가 물질
반응물 4
생성물 1
시약·촉매·용매 2
반응 조건
- 온도
- 60 °C
실험 절차
To a solution of (5-cyanopyridin-2-yl)(methyl)carbamic chloride (I-28) in THF (2.0 mL) were added 3-bromo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine (137 mg, 0.680 mmol), triethylamine (0.14 mL, 1.021 mmol) and 4-dimethylaminopyridine (2.0 mg, 0.017 mmol). The mixture was stirred at 60° C. for 1 h. Subsequently, water (25 mL) was added and the mixture was extracted with ethyl acetate. The organic layer was washed with brine, dried over Na2SO4 and the solvent was removed under reduced pressure. The resulting crude product was purified by preparative TLC to afford 60 mg (44%) of 3-bromo-N-(5-cyanopyridin-2-yl)-N-methyl-6,7-dihydropyrazolo-[1,5-a]pyrazine-5(4H)-carboxamide (I-29) as a off white solid. 1H NMR (400 MHz, DMSO) δ 8.64 (s, 1H), 8.07 (d, J=8.8 Hz, 1H), 7.60 (s, 1H), 7.18 (d, J=8.4 Hz, 1H), 4.53 (s, 2H), 4.16 (t, J=4.9 Hz, 2H), 3.84 (t, J=4.9 Hz, 2H), 3.26 (s, 3H); ESI-LC/MS (m/z): [M+H]+ 360.91, [(M+2)+H]+ 362.93, RT 1.63 min.
후처리
- extractionthe mixture was extracted with ethyl acetate
- washThe organic layer was washed with brine
- dry with materialdried over Na2SO4
- customthe solvent was removed under reduced pressure
- customThe resulting crude product was purified by preparative TLC
출처 및 근거
- ORD 기록
- ord-aba3283e3bf044949c194ea845d48b74
- 출처 데이터셋
- uspto-grants-2014_10
- 특허 번호
- US08871754B2
반응 노트
불러오는 중…